Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Carbon Dioxide Contrast Enhancement for C-Arm CT Utility for Treatment Planning during Hepatic Embolization Procedures.

Carbon Dioxide Contrast Enhancement for C-Arm CT Utility for Treatment Planning during Hepatic Embolization Procedures. Journal of vascular and interventional radiology Wong, A. A., Charalel, R. A., Louie, J. D., Sze, D. Y. 2013; 24 (7): 975-980

Abstract

A pilot study was performed to evaluate the use of carbon dioxide (CO2) as a contrast medium for C-arm computed tomography (CT). C-arm CT using CO2 was performed during embolization procedures in12 patients with hepatic malignancies and severe iodine allergy or high risk for nephrotoxicity. C-arm CT using gadolinium or iodinated contrast medium was performed for comparison. Of segmental arteries identified by conventional contrast enhancement, 96% were also seen with CO2 enhancement, but subsegmental arteries were not reliably depicted. CO2 enhancement identified 60% of tumors. Small, hypovascular, and infiltrative tumors were difficult to detect. CO2 is a promising alternative intraarterial contrast agent for C-arm CT.

View details for DOI 10.1016/j.jvir.2013.03.029

View details for PubMedID 23796085